Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Scared to death.

Ujhelyi MR.

Pharmacotherapy. 2008 Nov;28(11):1311-4. doi: 10.1592/phco.28.11.1311. No abstract available.

PMID:
18956990
2.

Baseline myocardial perfusion predicts response to cardiac resynchronization therapy: a prospective observational study.

Orlov MV, Maysky M, Akrivakis ST, Ujhelyi MR, Hoffmeister P, Shukla G, McAllister S, Kotler G, Almasry I, Chaudhry GM, Haffajee CI.

J Interv Card Electrophysiol. 2008 Nov;23(2):127-33. doi: 10.1007/s10840-008-9285-3. Epub 2008 Aug 7.

PMID:
18686023
3.
4.

Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias.

Xiao YF, Sigg DC, Ujhelyi MR, Wilhelm JJ, Richardson ES, Iaizzo PA.

Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2212-8. doi: 10.1152/ajpheart.91502.2007. Epub 2008 Mar 7.

5.

Interatrial conduction measured during biventricular pacemaker implantation accurately predicts optimal paced atrioventricular intervals.

Levin V, Nemeth M, Colombowala I, Massumi A, Rasekh A, Cheng J, Coles JA Jr, Ujhelyi MR, Razavi M.

J Cardiovasc Electrophysiol. 2007 Mar;18(3):290-5.

PMID:
17313655
6.

Focal pharmacological modulation of atrioventricular nodal conduction via implantable catheter: a novel therapy for atrial fibrillation?

Sigg DC, Hiniduma-Lokuge P, Coles JA Jr, Falkner P, Rose R, Urban JF, Ujhelyi MR.

Circulation. 2006 May 23;113(20):2383-90. Epub 2006 May 15.

PMID:
16702470
7.

Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam.

Fabian TJ, Schwartzman DS, Ujhelyi MR, Corey SE, Bigos KL, Pollock BG, Kroboth PD.

J Cardiovasc Electrophysiol. 2006 Apr;17(4):391-5.

PMID:
16643361
8.

Utility of adjunctive single oral bolus propafenone therapy in patients with atrial defibrillators.

Schwartzman D, Harvey MN, Hoyt RH, Koehler JL, Ujhelyi MR, Euler DE.

Europace. 2006 Mar;8(3):211-5. Epub 2006 Feb 7.

PMID:
16627442
9.

Intrathecal clonidine reduces the incidence of ischemia-provoked ventricular arrhythmias in a canine postinfarction heart failure model.

Issa ZF, Ujhelyi MR, Hildebrand KR, Zhou X, Rosenberger J, Groh WJ, Miller JM, Zipes DP.

Heart Rhythm. 2005 Oct;2(10):1122-7.

PMID:
16188594
10.

Understanding atrial symptom reports: objective versus subjective predictors.

Sears SF, Serber ER, Alvarez LG, Schwartzman DS, Hoyt RH, Ujhelyi MR.

Pacing Clin Electrophysiol. 2005 Aug;28(8):801-7.

PMID:
16105008
11.

Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine model.

Issa ZF, Zhou X, Ujhelyi MR, Rosenberger J, Bhakta D, Groh WJ, Miller JM, Zipes DP.

Circulation. 2005 Jun 21;111(24):3217-20. Epub 2005 Jun 13.

PMID:
15956128
12.

Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) Study.

Burns JL, Sears SF, Sotile R, Schwartzman DS, Hoyt RH, Alvarez LG, Ujhelyi MR.

J Cardiovasc Electrophysiol. 2004 Mar;15(3):286-91.

PMID:
15030417
13.

Better living through medical device technology.

Sims JJ, Ujhelyi MR.

Pharmacotherapy. 2004 Feb;24(2):298-305; discussion 305-6. Review. No abstract available.

PMID:
14998229
14.

Patient experiences with atrial fibrillation and treatment with implantable atrial defibrillation therapy.

Deaton C, Dunbar SB, Moloney M, Sears SF, Ujhelyi MR.

Heart Lung. 2003 Sep-Oct;32(5):291-9.

PMID:
14528186
15.

Sleep quality among patients treated with implantable atrial defibrillation therapy: effect of nocturnal shock delivery and psychological distress.

Serber ER, Sears SF, Sotile RO, Burns JL, Schwartzman DS, Hoyt RH, Alvarez LG, Ujhelyi MR.

J Cardiovasc Electrophysiol. 2003 Sep;14(9):960-4.

PMID:
12950541
16.

Electrical heterogeneity and arrhythmogenesis: importance of conduction velocity dispersion.

Sims JJ, Miller AW, Ujhelyi MR.

J Cardiovasc Pharmacol. 2003 May;41(5):795-803.

PMID:
12717112
17.

Intrapericardial therapeutics: a pharmacodynamic and pharmacokinetic comparison between pericardial and intravenous procainamide delivery.

Ujhelyi MR, Hadsall KZ, Euler DE, Mehra R.

J Cardiovasc Electrophysiol. 2002 Jun;13(6):605-11.

PMID:
12108506
18.

Lidocaine increases the proarrhythmic effects of monophasic but not biphasic shocks.

Sims JJ, Miller AW, Ujhelyi MR.

J Cardiovasc Electrophysiol. 2001 Dec;12(12):1363-8.

PMID:
11797993
19.

Defibrillation energy requirements and electrical heterogeneity during total body hypothermia.

Ujhelyi MR, Sims JJ, Dubin SA, Vender J, Miller AW.

Crit Care Med. 2001 May;29(5):1006-11.

PMID:
11378613
20.

Enhanced endothelin-1 response and receptor expression in small mesenteric arteries of insulin-resistant rats.

Katakam PV, Pollock JS, Pollock DM, Ujhelyi MR, Miller AW.

Am J Physiol Heart Circ Physiol. 2001 Feb;280(2):H522-7.

21.

Comparison of the pharmacokinetics and in vivo bioaffinity of DigiTAb versus Digibind.

Ward SB, Sjostrom L, Ujhelyi MR.

Ther Drug Monit. 2000 Oct;22(5):599-607.

PMID:
11034267
22.

Cytochrome P450 activity and endothelial dysfunction in insulin resistance.

Katakam PV, Hoenig M, Ujhelyi MR, Miller AW.

J Vasc Res. 2000 Sep-Oct;37(5):426-34.

PMID:
11025406
23.

Endotoxemia alters splanchnic capacitance.

Ujhelyi MR, Miller AW, Raibon S, Corley J, Robinson VJ, Sims JJ, Tonnessen T, Burke G, Ilebekk A, Rutlen DL.

Shock. 2000 Jul;14(1):68-72.

PMID:
10909896
24.

Regional hyperkalemia increases ventricular defibrillation energy requirements: role of electrical heterogeneity in defibrillation.

Sims JJ, Miller AW, Ujhelyi MR.

J Cardiovasc Electrophysiol. 2000 Jun;11(6):634-41.

PMID:
10868736
25.

Mechanisms of Impaired Endothelial Function Associated With Insulin Resistance.

Miller AW, Hoenig ME, Ujhelyi MR.

J Cardiovasc Pharmacol Ther. 1998 Apr;3(2):125-134.

PMID:
10684490
26.

Metformin improves vascular function in insulin-resistant rats.

Katakam PV, Ujhelyi MR, Hoenig M, Miller AW.

Hypertension. 2000 Jan;35(1 Pt 1):108-12.

PMID:
10642283
27.
28.

Impaired endothelium-mediated relaxation in coronary arteries from insulin-resistant rats.

Miller AW, Katakam PV, Ujhelyi MR.

J Vasc Res. 1999 Sep-Oct;36(5):385-92.

PMID:
10559679
29.

Action potentials that mimic fibrillation activate sodium current.

Ujhelyi MR, Creazzo TL.

J Mol Cell Cardiol. 1999 Sep;31(9):1673-84.

PMID:
10471351
30.

EDHF-mediated relaxation is impaired in fructose-fed rats.

Katakam PV, Ujhelyi MR, Miller AW.

J Cardiovasc Pharmacol. 1999 Sep;34(3):461-7.

PMID:
10471008
31.

Impaired vagal reflex activity in insulin-resistant rats.

Miller AW, Sims JJ, Canavan A, Hsu T, Ujhelyi MR.

J Cardiovasc Pharmacol. 1999 May;33(5):698-702.

PMID:
10226855
32.

Endothelial dysfunction precedes hypertension in diet-induced insulin resistance.

Katakam PV, Ujhelyi MR, Hoenig ME, Miller AW.

Am J Physiol. 1998 Sep;275(3 Pt 2):R788-92.

PMID:
9728076
33.

Disparate effects of biphasic and monophasic shocks on postshock refractory period dispersion.

Sims JJ, Miller AW, Ujhelyi MR.

Am J Physiol. 1998 Jun;274(6 Pt 2):H1943-9.

PMID:
9841521
34.

High-dose lidocaine does not affect defibrillation efficacy: implications for defibrillation mechanisms.

Ujhelyi MR, Sims JJ, Miller AW.

Am J Physiol. 1998 Apr;274(4 Pt 2):H1113-20.

PMID:
9575914
35.

Lidocaine's effect on defibrillation threshold are dependent on the defibrillation electrode system: epicardial versus endocardial.

Winecoff Miller AP, Sims JJ, McSwain R, Ujhelyi MR.

J Cardiovasc Electrophysiol. 1998 Mar;9(3):312-20.

PMID:
9554736
36.

Importance of nitric oxide in hepatic arterial blood flow and total hepatic blood volume regulation in pigs.

Grund F, Sommerschild HT, Winecoff A, Ujhelyi MR, T√łnnessen T, Kirkeb√łen KA, Rutlen DL, Ilebekk A.

Acta Physiol Scand. 1997 Nov;161(3):303-9.

PMID:
9401582
37.

Lidocaine does not affect myocardial electrical heterogeneity: implications for low proarrhythmic actions.

Sims JJ, Winecoff AP, Ujhelyi MR.

Pharmacotherapy. 1997 Nov-Dec;17(6):1267-73.

PMID:
9399610
38.

Assessment of tricyclic antidepressant toxicity: looking for a needle in a pharmacologic haystack.

Ujhelyi MR.

Crit Care Med. 1997 Oct;25(10):1634-6. Review. No abstract available.

PMID:
9377874
39.

Aging effects on the organic base transporter and stereoselective renal clearance.

Ujhelyi MR, Bottorff MB, Schur M, Roll K, Zhang H, Stewart J, Markel ML.

Clin Pharmacol Ther. 1997 Aug;62(2):117-28.

PMID:
9284847
40.

Pinacidil's Effects on Defibrillation Outcomes: Role of Increased Potassium Conductance Via the K(ATP) Channel.

Winecoff AP, Sims JJ, Markel ML, Ujhelyi MR.

J Cardiovasc Pharmacol Ther. 1997 Jul;2(3):171-180.

PMID:
10684456
41.

Hypertonic saline does not reverse the sodium channel blocking actions of lidocaine: evidence from electrophysiologic and defibrillation studies.

Ujhelyi MR, Schur M, Frede T, Bottorff MB, Gabel M, Markel ML.

J Cardiovasc Pharmacol. 1997 Jan;29(1):61-8.

PMID:
9007672
42.

Influence of hypertonic saline solution infusion on defibrillation efficacy.

Ujhelyi MR, Winecoff AP, Schur M, Frede T, Bottorff MB, Gabel M, Markel ML.

Chest. 1996 Sep;110(3):784-90.

PMID:
8797427
43.

Measurement and analysis of unbound drug concentrations.

Wright JD, Boudinot FD, Ujhelyi MR.

Clin Pharmacokinet. 1996 Jun;30(6):445-62. Review.

PMID:
8792057
44.

Mechanism of antiarrhythmic drug-induced changes in defibrillation threshold: role of potassium and sodium channel conductance.

Ujhelyi MR, Schur M, Frede T, Bottorff MB, Gabel M, Markel ML.

J Am Coll Cardiol. 1996 May;27(6):1534-42.

45.

Disposition of intravenous amiodarone in subjects with normal and impaired renal function.

Ujhelyi MR, Klamerus KJ, Vadiei K, O'Rangers E, Izard M, Neefe DL, Zimmerman JJ, Chow MS.

J Clin Pharmacol. 1996 Feb;36(2):122-30.

PMID:
8852388
46.

Urine acidification affects the activity of the organic base transporter in a nonstereoselective manner.

Ujhelyi MR, Bottorff MB, Schur M, Roll K, Zhang H, Stewart J, Markel ML.

J Pharmacol Exp Ther. 1996 Feb;276(2):683-9.

PMID:
8632337
47.

Differential effects of lidocaine on defibrillation threshold with monophasic versus biphasic shock waveforms.

Ujhelyi MR, Schur M, Frede T, Gabel M, Markel ML.

Circulation. 1995 Sep 15;92(6):1644-50.

PMID:
7664452
48.

Lorazepam versus midazolam for sedation.

Ujhelyi MR.

Crit Care Med. 1995 Jun;23(6):1152-3. No abstract available.

PMID:
7774232
49.

Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity.

Ujhelyi MR, Robert S.

Clin Pharmacokinet. 1995 Jun;28(6):483-93. Review.

PMID:
7656506
50.

Role of exogenous adenosine as a modulator of theophylline toxicity.

Ujhelyi MR, Hulula G, Skau KA.

Crit Care Med. 1994 Oct;22(10):1639-46.

PMID:
7924377

Supplemental Content

Loading ...
Support Center